Citation Select	Marcellaud E, Jost J, Tchalla A, Magne J, Aboyans V Statins in Primary Prevention in People Over 80 Years Am J Cardiol. 2023 Jan 15;187:62-73. doi: 10.1016/j.amjcard.2022.10.015
Citation Select	Orkaby , Driver , Ho , Lu , Costa , Honerlaw , Galloway , Vassy , Forman , Gaziano , Gagnon , Wilson , Cho , Djousse Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older JAMA. 2020 Jul 7;324(1):68-78. doi: 10.1001/jama.2020.7848
Citation Select	Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N Engl J Med. 2016 May 26;374(21):2021-31
Citation Select	Strandberg TE, Kolehmainen L, Vuorio A Evaluation and treatment of older patients with hypercholesterolemia: a clinical review JAMA. 2014 Sep 17;312(11):1136-44
Citation Select	Geng Q, Ren Department of Cardiology, Peking University People,s Hospital, Beijing, China., Song Department of Cardiology, Peking University People,s Hospital, Beijing, China., Li Department of Cardiology, Peking University People,s Hospital, Beijing, China., Chen Department of Cardiology, Peking University People,s Hospital, Beijing, China. Electronic address: chenhongbj@medmail.com.cn., Meta-Analysis of the Effect of Statins on Renal Function. Am J Cardiol. 2014 Jun 6. [Epub ahead of print]
Citation Select	Savarese G, Gotto Jr, Paolillo S, D,Amore C, Losco T, Musella F, Scala O, Marciano C, Ruggiero D, Marsico F, De Luca G, Trimarco B, Perrone-Filardi P Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis J Am Coll Cardiol. 2013 Dec 3;62(22):2090-9
Citation Select	Hou W, Lv J, Perkovic V, Yang L, Zhao N, Jardine MJ, Cass A, Zhang H, Wang H Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis Eur Heart J. 2013 Jun;34(24):1807-17. Epub 2013 Mar 6.
Citation Select	Taylor Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. Fiona.Taylor@lshtm.ac.uk., Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev. 2013;1:CD004816
Citation Select	JUPITER Study Group; Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med. 2008 Nov 20;359(21):2195-207
Citation Select	Afilalo J, Duque G, Steele R, Jukema JW, de Craen AJ, Eisenberg MJ, Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol. 2008 Jan 1;51(1):37-45
Citation Select	West of Scotland Coronary Prevention Study Group; Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM Long-term follow-up of the West of Scotland Coronary Prevention Study N Engl J Med. 2007 Oct 11;357(15):1477-86
Citation Select	Robinson JG, Smith B, Maheshwari N, Schrott H Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis J Am Coll Cardiol. 2005 Nov 15;46(10):1855-62. Epub 2005 Oct 24
Citation Select	Cholesterol Treatment Trialists- (CTT) Collaborators; Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet. 2005 Oct 8;366(9493):1267-78. Epub 2005 Sep 27
Citation Select	Briel M, Studer M, Glass TR, Bucher HC Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials Am J Med. 2004 Oct 15;117(8):596-606
Citation Select	Collins R, Armitage J, Parish S, Sleight P, Peto R; Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet. 2004 Mar 6;363(9411):757-67
Citation Select	PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk; Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet. 2002 Nov 23;360(9346):1623-30
Citation Select	Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet. 2002 Jul 6;360(9326):7-22
Citation Select	The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med. 1998 Nov 5;339(19):1349-57
Citation Select	Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial Ann Intern Med. 1998 Nov 1;129(9):681-9